Markers to help newly diagnosed seropositive rheumatoid arthritis patients
Researchers collected clinical and laboratory measures from 28 UK centres every 3 months over a total of 18 months to understand the progression of seropositive rheumatoid arthritis.
It was measured against the 28-joint Disease Activity Score with C-reactive protein (DAS28-CRP) and Simplified Disease Activity Index (SDAI).
Researchers found that collecting biological markers early after diagnosis could help manage the disease.
Read the full paper published in October 2021